Get started
Author

Lassané Kaboré

Observed names: Kaboré, Lassané, L Kabore, Lassane Kabore, Lassané Kabore
Institution: Gavi
OpenAlex ID: A5034087604
Facilitating the development of urgently required combination vaccines
2024 · William P Hausdorff, Shabir A Madhi, et al. · The Lancet Global Health · 53
PDF
Self-Report Measures in the Assessment of Antiretroviral Medication Adherence
2014 · Lassane Kabore, Paul Muntner, et al. · Journal of the International Association of Providers of AIDS Care (JIAPAC) · 53
Assessment of missed opportunities for vaccination (MOV) in Burkina Faso using the World Health Organization’s revised MOV strategy: Findings and strategic considerations to improve routine childhood immunization coverage
2020 · Lassané Kaboré, Bertrand Meda, et al. · Vaccine · 37
PDF
Missed opportunities for vaccination among children aged 0–23 months visiting health facilities in a southwest State of Nigeria, December 2019
2021 · Akinola Ayoola Fatiregun, Laura Nic Lochlainn, et al. · PLoS ONE · 30
PDF
Impact of 13-valent pneumococcal conjugate vaccine on the incidence of hospitalizations for all-cause pneumonia among children aged less than 5 years in Burkina Faso: An interrupted time-series analysis
2020 · Lassané Kaboré, Seydou Ouattara, et al. · International Journal of Infectious Diseases · 23
PDF
Pharmacovigilance Systems in Developing Countries: An Evaluative Case Study in Burkina Faso
2013 · Lassane Kabore, Pascal Millet, et al. · Drug Safety · 20
Task-Shifting Immunization Activities to Community Health Workers: A Mixed-Method Cross-Sectional Study in Sahel Region, Burkina Faso
2023 · Hamed Sidwaya Ouédraogo, Yewayan Larba Berenger Kabore, et al. · Global Health Science and Practice · 16
PDF
Quality and reliability of vaccination documentation in the routine childhood immunization program in Burkina Faso: Results from a cross-sectional survey
2020 · Lassané Kaboré, Clément Z. Méda, et al. · Vaccine · 15
Exploring Shigella vaccine priorities and preferences: Results from a mixed-methods study in low- and middle-income settings
2023 · Jessica A. Fleming, Nikki Gurley, et al. · Vaccine X · 14
Effects of the free healthcare policy on health services’ usage by children under 5 years in Burkina Faso: a controlled interrupted time-series analysis
2022 · Siaka Debe, Patrick G Ilboudo, et al. · BMJ Open · 12
PDF
Pneumococcal Carriage in Burkina Faso After 13-Valent Pneumococcal Conjugate Vaccine Introduction: Results From 2 Cross-sectional Population-Based Surveys
2021 · Lassané Kaboré, Tolulope Adebanjo, et al. · The Journal of Infectious Diseases · 12
PDF
Impact of Introducing Hepatitis B Birth Dose Vaccines into the Infant Immunization Program in Burkina Faso: Study Protocol for a Stepped Wedge Cluster Randomized Trial (NéoVac Study)
2021 · Haoua Tall, Pierrick Adam, et al. · Vaccines · 9
PDF
Lassa fever vaccine use cases and demand: Perspectives from select West African experts
2024 · Lassané Kaboré, Clint Pecenka, et al. · Vaccine · 8
Plaidoyer pour un renforcement du système de pharmacovigilance au Burkina Faso
2018 · Lassané Kaboré, Téné Marceline Yaméogo, et al. · Santé Publique · 8
Pneumococcal vaccine implementation in the African meningitis belt countries: the emerging need for alternative strategies
2021 · Lassané Kaboré, Annick Galetto-Lacour, et al. · Expert Review of Vaccines · 7
Surveillance des effets indésirables lors des campagnes de la chimioprévention du paludisme saisonnier chez les enfants de 3-59 mois au Burkina Faso
2023 · Joël Ouoba, Sougrimani Lankoandé-Haro, et al. · Santé Publique · 6
PDF
Casualty care in a low-resource conflict setting: injury epidemiology and management among military personnel in Burkina Faso from 2020 to 2024
2025 · S Yves G Sanou, P S S Bingboure, et al. · BMJ Military Health · 4
Evaluation of the Med Safety mobile app for reporting adverse events in Burkina Faso
2024 · Joël Ouoba, Sougrimani Haro-Lankoandé, et al. · Drugs & Therapy Perspectives · 4
PDF
Actions of the National Regulatory Authorities in 10 Low- and Middle-Income Countries Following Stringent Regulatory Authority Safety Alerts on Rosiglitazone
2014 · Jude Nwokike, Lassane Kabore, et al. · Therapeutic Innovation & Regulatory Science · 3
Accelerating Evidence-Informed Vaccine Introductions: Lessons from the Hexavalent Early Adopters Workshop
2026 · Kathryn L. Hopkins, Sidy Ndiaye, et al. · Vaccines · 1
Informing an mpox stockpile investment case: epidemiological modelling and cost–benefit analysis
2026 · Dionne Mitcham, Richard Bruns, et al. · The Lancet Global Health
Correction: Missed opportunities for vaccination among children aged 0–23 months visiting health facilities in a southwest State of Nigeria, December 2019
2025 · Akinola Ayoola Fatiregun, Laura Nic Lochlainn, et al. · PLoS ONE
PDF
Analyses de livres
2018 · Kaboré, Lassané, Yaméogo, Téné Marceline, et al. · Santé Publique
PDF
Works count: 23
Citation count: 335
H-index: 11
I10-index: 11
Year
Topic
Type